CD34 is a target for covalent EGFR inhibitors to eliminate stem/progenitor cells in acute and chronic myeloid leukemia
Ying Lu(Ministry of Education), Jinsong Yan(Dalian Medical University)
Cited by 0
Related Papers
Mitochondrial oxidative phosphorylation is dispensable for survival of CD34+ chronic myeloid leukemia stem and progenitor cells
|Cell Death and Disease|2022|32
A global study for acute myeloid leukemia with <i>RARG</i> rearrangement
|Blood Advances|2023|26
Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway
|Frontiers in Pharmacology|2021|22